凯赛生物

- 688065

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
凯赛生物(688065) 利润表
单位:万元
报表日期2025-03-312024-12-312024-09-302024-06-302024-03-31
一、营业总收入77,576.99295,791.16221,508.34144,429.3068,452.15
营业收入77,576.99295,791.16221,508.34144,429.3068,452.15
二、营业总成本61,936.86236,127.30180,677.37115,308.3755,974.34
营业成本51,485.06203,366.68150,185.7799,333.6448,818.05
营业税金及附加924.053,578.832,747.471,850.80867.15
销售费用1,364.175,457.674,053.992,668.391,229.06
管理费用4,302.2816,791.2513,170.808,551.224,324.40
财务费用-2,193.76-16,401.07-6,359.85-7,101.07-3,742.75
研发费用6,055.0623,333.9316,879.1810,005.404,478.43
资产减值损失----------
公允价值变动收益----------
投资收益-261.61-895.18-501.63-381.64-166.48
其中:对联营企业和合营企业的投资收益-261.61-895.18-501.63-381.64-166.48
汇兑收益----------
三、营业利润16,168.5755,156.1238,909.8028,051.4412,346.38
加:营业外收入34.66104.1464.4547.5734.75
减:营业外支出399.15458.74237.0812.221.64
其中:非流动资产处置损失----------
四、利润总额15,804.0954,801.5238,737.1728,086.8012,379.49
减:所得税费用3,372.227,342.594,893.803,676.061,693.73
五、净利润12,431.8747,458.9333,843.3724,410.7410,685.76
归属于母公司所有者的净利润13,695.0148,896.1934,517.7424,744.5610,525.87
少数股东损益-1,263.14-1,437.26-674.37-333.82159.89
六、每股收益
基本每股收益(元/股)0.23000.84000.59000.42000.1800
稀释每股收益(元/股)0.23000.84000.59000.42000.1800
七、其他综合收益386.25-548.6821.68-279.30-207.60
八、综合收益总额12,818.1246,910.2633,865.0624,131.4410,478.17
归属于母公司所有者的综合收益总额14,081.2648,347.5134,539.4324,465.2610,318.27
归属于少数股东的综合收益总额-1,263.14-1,437.26-674.37-333.82159.89
下载全部历史数据到excel中 返回页顶